Document Type : Review Article
Authors
1 Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Northern Border University, Rafha 91911, PO Box 840, Saudi Arabia
2 Department of Pharmacy, Himalayan Institute of Pharmacy and Research, Dehradun, (Uttarakhand), 248007, India
Abstract
Most currently used nonsteroidal anti-inflammatory drugs (NSAIDs) have restrictions for therapeutic use since they cause gastrointestinal and renal side effects that are undividable from their pharmacological activities. In this review various piperazinyl containing pyridazine derivatives have been studied for their analgesic and anti-inflammatory activities and their side effects. Therefore, the synthesis of new compounds devoid of such side effects has become an important goal for medicinal chemists.
Graphical Abstract
)
Keywords
Main Subjects
References
[1] P. Brooks, P. Emery, J.F. Evans, H. Fenner, C.J. Hawkey, C. Patrono, J. Smolen, F. Breedveld, R. Day, M. Dougados, E.W. Ehrich, J. Gijon-Banos, T.K. Kvien, M.H. Van Rijswijk, T. Warner and H. Zeidler, Rheumatology, 38 (1999), 779-88 (1999).
[2] S. Leone, A. Ottani, and A. Bertolini, Curr. Topics Med. Chem., 7 (2007), 265-75.
[3] V. Dal Piaz, M.P. Giovannoni, G. Ciciani, D. Barlocco, G. Giardina, G. Petrone and G.D. Clarke, Eur. J. Med. Chem., 31 (1996), 65-70.
[4] P. Coudert, C. Rubat, F. Rohet, F. Leal, J. Fialip and J. Couquelet, Pharm. Pharmacol. Commun., 6 (2000), 387-96.
[5] V.K. Chintakunta, V. Akella, M.S. Vedula, P.K. Mamnoor, P. Mishra, S.R. Casturi, A. Vangoori and R. Rajagopalan, Eur. J. Med. Chem., 37 (2002), 339-47.
[6] D.S. Dogruer, M.F. Sahin, S. Unlu and I. Shigeru, Arch. Pharm. Pharm. Med. Chem., 333 (2000), 79-86.
[7] A.S. Kalgutkar, A.B. Marnett, B.C. Crews, R.P. Remel and L.J. Marnett, J. Med. Chem., 43 (2000), 2860-70.
[8] A.S. Kalgutkar, S.W. Rowlinson, B.C. Crews and L.J. Marnett, Bioorg. Med. Chem. Lett., 12 (2002), 521-24.
[9] J.G. Hashash, L.A. Atweh, T. Saliba, and Z. Chakhachiro. ClinTherapeut, 29 (2007), 2448-2452.
[10] W.A. Ray, C.P. Chung, C.M. Stein, W.E. Smalley, K. Hall, P.G. Arbogast, and M.R. Griffin. Gastroenterol, 133(2007), 790-798.
[11] J. L. Marco, P. Amariles, B. Bosca, and A. Castello, Curr. Ther. Res., 68(2007), 107-119.
[12] T. Funatsu, K. Chono, T. Hirata, Y. Keto, A. Kimoto, and M. Sasamata, Eur. J. Pharmacol., 554(2007), 53-59.
[13] F. Odabasoglu, A. Cakır, H. Suleyman, A. Aslan, Y. Bayir, M. Halici, and C. Kazaz, J Ethnopharmacol, 103(2006), 59-65.
[14] S.A.F. Rostom, I.M. El-Ashmawy, H.A. Abd El Razik, M.H. Badr, and H.M.A. Ashour, Bioorg. Med. Chem., 17 (2009) 882-895.
[15] A.A. Bekhit, and T. Abdel-Azneim, Bioorg. Med. Chem., 12(2004), 1935-1945.
[16] S.C. Jain, J. Sinha, S. Bhagat, W. Errington, and C.E. Olsen, Synth. Commun., 33(2003) 563-577.
[17] S. Bondock, R. Rabie, H.A. Etman, and A.A. Fadda, Eur. J. Med. Chem., 43(2008), 2122-2129.
[18] B. Meunier, Accounts Chem. Res., 41(2008), 69-77.
[19] P. Coudert, E. Albusson, J.Y. Boire, J.Y. Duroux, P. Bastıde and J. Couqelet, Eur. J. Med. Chem., 29(1994), 471-477.
[20] M. Takaya and M. Sato, YakugakuZasshi, 114 (1994), 94-110.
[21] G. Heinisch and H. Frank, Prog. Med. Chem., 27(1990), 1-35 (1990).
[22] F. Rohet, C. Rubat, P. Coudert, E. Albuisson and J. Couquelet, Chem. Pharm. Bull., 44 (1996), 980-86.
[23] D.S. Dogruer, M.F. Sahin, S. Unlu and S. Ito, Arch. Pharm., 333(2000), 79-86.
[24] S.S.H. Davarani, Z. Rezayati-zad, A. Taheri, N. Rahmatian, Materials science & engineering C, Materials for biological applications, 71(2017) 572-583.
[25] A.S. Kalgutkar, A.B. Marnett, B.C. Crews, R.P. Remmel, and L.J. Marnett, J. Med. Chem., 43 (2000), 2860-2870.
[26] T. Onkol, M.F. Sahin, E. Yildirim, K. Erol, and S. Ito, Arch. Pharm. Res., 27 (2004), 1086-1092.
[27] S. Unlu, S.N. Baytas, E. Kupeli, and E. Yesilada, Arch. Pharm. Pharm. Med. Chem., 336 (2003), 310-321.
[28] T. Onkol, E. Yildirim, K. Erol, S. Ito, and M.F. Sahin, Arch. Pharm. Pharm. Med Chem., 337 (2004), 475-481.
[29] Z. Rezayati-zad, S.S.H. Davarani, A. Taheri, Y. Bide, Biosens Bioelectron, 86(2016) 616-22..
[30] M.C. Viaud, P. Jamoneau, C. Flouzat, J,G.B. Espiard, B. Pfeiffer, P. Renard, D.H. Caignard, G. Adam, and G. Guillaumet, J. Med. Chem., 38 (1995), 1278-1286.
[31] V. Dal Piaz, C. Vergelli, P. Giovannoni, M.A. Scheideler, G. Petrone, and P. Zaratin, Farmaco, 58 (2003), 1063-1070.
[32] E. Banoglu, C. Akoglu, S. Unlu, E. Kupeli, E. Yesilada, and M.F. Sahin, Arch. Pharm. Pharm. Med. Chem., 337(2004), 7-14.
[33] D.S. Dogruer, M.F. Sahin, S. Unlu, and S. Ito, Arch. Pharm. Pharm. Med. Chem., 333 (2000), 79-86.
[34] M.F. Sahin, B. Badicoglu, M. Cokce, E. Kupeli, and E. Yesilada, Arch. Pharm. Pharm. Med. Chem., 337(2004), 445-452.
[35] H.M. Refaat, O.M. Khalil, and H.H. Kadry, Arch Pharm Res, 30(2007), 803-811.
[36] D.S. Dogruer, M.F. Sahin, E. Kupeli, and E. Yesilada,Turk J Chem, 27 (2003), 727-738.
[37] P. Coudert, E. Duroux, P. Bastide, J. Couquelet and P. Tronche, J. Pharm. Belg., 46 (1991), 375-80.
[38] S. Baytas, N. Inceler, K.F Mavaneh, M.O. Uludag, N. Abacioglu, and M. Gokce, Turk J Chem, 36 (2012), 734-748.
[39] A.S. Kalgutkar, S.W. Rowlinson, B.C. Crews, and L.J. Marnett, Bioorg. Med. Chem. Lett., 12 (2002), 521-524.
[40] D.S. Dogruer, M.F. Sahin, S. Unlu, and I. Shigeru, Arch. Pharm. Pharm. Med. Chem., 333(2000), 79-86.
[41] V.A. Chatpaliwar, A.A. Johrapurkar, M.M. Wanjari, R.R. Chakraborty, and V.T. Kharkar, Indian Drugs, 39(2002), 543-545.
[42] E. Kupeli, I. Tatlı, Z.S. Akdemir, and E. Yesilada, J. Ethnopharmacol., 114(2007) 234-240.
[43] E. Yesilada, and I. Gurbuz, J. Ethnopharmacol., 131(2010), 17-21.
[44] C.A. Lipinski, F. Lombardo, B.W. Dominy, and P. Feeney, J. Adv. Drug Deliv. Rev., 46(2001), 3-26.
[45] E. Banoglu, M.S. Ukuroglu, B.C. Alis, K. Ergun, S.N. Baytas, E. Aypar, and M. Ark, Turk J Chem, 31(2007), 677- 687.
[46] S. Moreau, P. Coudert, C. Rubat, E. Albuisson and J. Couquelet, Arzneim.-Forsch./Drug Res., 46(1996), 800-05.
[47] B. Okcelik, S. Unlu, E. Banoglu, E. Kupeli, E. Yesilada and M.F. Sahin, Arch. Pharm. Pharm. Med. Chem., 336(2003), 406-12.
[48] S. Pieretti, V. Dal Piaz, R. Matucci, M.P. Giovannoni and A. Galli, Life Sci., 65 (1999), 1381-94.
[49] F. Rohet, C. Rubat, P. Coudert, E. Albuisson and J. Couquelet, Chem. Pharm. Bull., 44 (1996), 980-86.
[50] S. Altug, O. Uludag, B. Tunctan, I. Cakici, H. Zengil and N. Abacioglu, Chronobiol. Int., 23 (2006), 583-591.
[51] Y. Dundar, M. Gokce, E. Kupeli, and M.F. Sahin, Arzneim. Forsch. Drug Res. 57 (2007), 777-781.
[52] C. Rubat, P. Coudert, E. Albuisson, J. Bastide, J. Couquelet and P. Tronche, J. Pharm. Sci., 81 (1992), 1084-87.
[53] M. Gokce, D. Dogruer and M.F. Sahin, Farmaco, 56 (2001), 233-37.
[54] K. Tsuji, K. Nakamura, N. Konishi, T. Tojo, T. Ochi, H. Senoh and M. Matsuo, Chem. Pharm. Bull., 45 (1997), 987-99.
[55] J.J. Talley, S.R. Bertenshaw, J.S. Carter, P.W. Collins, S. Docter, M.J. Graneto, P.C. Isakson, L.F. Lee, J.W. Malecha, J.M. Miyashiro, T.D. Penning, R.S. Rogers, D.J. Rogier, S.S. Yu, G.D. Anderson, E.G. Burton, J.N. Cogburn, S.A. Gregory, C.M. Koboldt, W.E. Perkins, K. Seibert, A.W. Veehuizen and Y.Y. Zhang, Act. Chim. Therap., 25 (1999), 123-134
|
HOW TO CITE THIS ARTICLE Md. Tauqir Alam, Abida, and M. ,A Review on Analgesic and Anti-Inflammatory Activities of Various iperazinyl Containing Pyridazine Derivatives, Prog. Chem. Biochem. Res. 2020, 3(2), 81-92. DOI: 10.33945/SAMI/PCBR.2020.2.1 URL: http://www.pcbiochemres.com/article_106473.html |
)
